Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Affiliation country
Publication year range
1.
BMJ Open ; 8(3): e017693, 2018 03 30.
Article in English | MEDLINE | ID: mdl-29602836

ABSTRACT

OBJECTIVES: The purpose of this study is to analyse hospital charges for patients with haemorrhagic stroke in China and investigate potential factors associated with inpatient charges. METHODS: The study participants were in-hospital patients with a primary diagnosis of haemorrhagic stroke from all the secondary and tertiary hospitals in Beijing during the period from 1 March 2012 to 28 February 2015. Distribution characteristics of detailed hospital charges were analysed. The influence of potential factors on hospital charges was researched using a stepwise multiple regression model. RESULTS: A total of 34 890 patients with haemorrhagic stroke of mean age 61.19±14.37 years were included in the study, of which 37.2% were female. Median length of hospital stay (LOHS) was 15 days (IQR 9-23) and median hospital cost was 18 577 Chinese yuan (CNY) (IQR 10 442-39 784). The hospital costs for patients in Western medicine hospitals (median 19 651 CNY) were significantly higher (P<0.01) than those in traditional Chinese medicine hospitals (median 14 560 CNY), and were significantly higher (P<0.01) for Level 3 hospitals (median 20 029 CNY) than for Level 2 hospitals (median 16 095 CNY). The proportion of medicine fees and bed fees within total hospital charges showed a decreasing trend during the study period. With stepwise multiple regression, the major factors associated with hospital charges were LOHS, surgery, pulmonary infection, ventilator usage, hospital level, occupation, hyperlipidaemia, hospital type, in-hospital death, sex and age. CONCLUSION: We conclude that medicines form the largest part of hospital charges but are showing a decreasing trend, and LOHS is strongly associated with patient charges for haemorrhagic stroke in China. This implies that the cost structure is very unreasonable in China and medical technology costs fail to be fully manifested. A reasonable decrease in medicine charges and shortening LOHS may be effective ways to reduce hospital charges.


Subject(s)
Cerebral Hemorrhage , Hospital Charges , Stroke , Aged , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/economics , China , Female , Humans , Length of Stay , Male , Middle Aged , Retrospective Studies , Stroke/complications , Stroke/economics
2.
Zhongguo Zhong Yao Za Zhi ; 39(16): 3123-7, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25509299

ABSTRACT

In this paper, the content of moisture, ethanol-soluble extractives, total saponins and polysaccharide of different tuber samples of Hemsleya zhejiangensis, from different localities, years and seasons, were detected based upon Chinese Pharmacopoeia 2010 version. The samples of roots, stems and leaves in summer were detected as well. The results are mainly as follows. (1)With tuber quality increasing, the content of total saponins increased and then decreased. The individual quality of tubers getting 594.06 g, the content of total saponins reached the peak. (2) The content of active ingredients in different localities was significantly different, and the population of Wuyanling had the maximum content of total saponins and polysaccharide. (3) The content of active ingredients revealed stability between the years 2012 and 2013, but the content of polysaccharide was significantly different. The content in 2012 was higher than that of 2013. (4) The content of active ingredients reached the peak in autumn, which was the best harvest season. (5) Among different component content detection of nutritional organs, tubers had the maximum content of ethanol-soluble extractives, total saponins and polysaccharide. Leaves also contained higher content of ethanol-soluble extractives and total saponins than roots and stems. All of these provide theoretical basis for plant, harvest and production of H. zhejiangensis, which is an endemic, rare, and endangered medicinal plants.


Subject(s)
Cucurbitaceae/chemistry , Cucurbitaceae/growth & development , Drugs, Chinese Herbal/analysis , China , Cucurbitaceae/metabolism , Drugs, Chinese Herbal/metabolism , Plant Leaves/chemistry , Plant Leaves/growth & development , Plant Leaves/metabolism , Plant Roots/chemistry , Plant Roots/growth & development , Plant Roots/metabolism , Plant Tubers/chemistry , Plant Tubers/growth & development , Plant Tubers/metabolism , Plants, Medicinal/chemistry , Plants, Medicinal/growth & development , Plants, Medicinal/metabolism
3.
J Pharm Biomed Anal ; 48(1): 100-4, 2008 Sep 10.
Article in English | MEDLINE | ID: mdl-18678457

ABSTRACT

To control the quality of Salvia plebeia R.Br., a simple and reliable method of high-performance liquid chromatography coupled with photodiode array detector (HPLC-DAD) was developed both for fingerprint analysis and quantitative determination of seven bioactive compounds, namely caffeic acid, luteolin-7-glucoside, nepetin-7-glucoside, homoplantaginin, luteolin, nepetin and hispidulin. In fingerprint analysis, twelve peaks were selected as characteristic peaks. In quantitative analysis, seven compounds showed good regression (R2>0.9995) within test ranges and the recovery of the method was in the range of 91.7-103.2%. The content ranges (mg/g) of seven compounds in the collected samples of S. plebeia were 0.80-1.67 (hispidulin), 2.18-5.75 (homoplantaginin), 0.52-1.22 (nepetin), 1.56-3.48 (nepetin-7-glucoside), 0.12-0.24 (luteolin), 0.97-2.22 (luteolin-7-glucoside) and 0.21-0.44 (caffeic acid), respectively. From the results obtained, the content of homoplantaginin was the highest. In addition, luteolin and luteolin-7-glucoside were isolated for the first time from S. plebeia.


Subject(s)
Chromatography, High Pressure Liquid/methods , Drugs, Chinese Herbal/analysis , Plant Extracts/analysis , Salvia/chemistry , Salvia/classification , Caffeic Acids/analysis , Caffeic Acids/chemistry , Drugs, Chinese Herbal/chemistry , Flavones/analysis , Flavones/chemistry , Flavonoids/analysis , Flavonoids/chemistry , Glucosides/analysis , Glucosides/chemistry , Luteolin/analysis , Luteolin/chemistry , Molecular Structure , Plant Extracts/chemistry , Quercetin/analogs & derivatives , Quercetin/analysis , Quercetin/chemistry , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL